No Data
No Data
Lifecore Biomedical Searches for New Auditor for Fiscal Year 2024
Lifecore Biomedical (LFCR) said Tuesday that Ernst & Young LLP declined to be reappointed as the company's independent registered public accounting firm for its fiscal year ending May 26, 2024, follow
Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update
CHASKA, Minn., March 26, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ:LFCR) ("Lifecore" or the "Company"), a fully integrated contract development and manufacturing organization ("CDMO"), announced today
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Lifecore Biomedical Announces New CEO and Equity Inducement Plan
Dow Surges 350 Points; Fed Holds Rates Steady
U.S. stocks traded higher toward the end of trading, after the Federal Reserve left rates unchanged. The Dow traded up 0.91% to 39,467.76 while the NASDAQ rose 1.08% to 16,341.42. The S&P 500 also ros
Top Midday Decliners
Lifecore Biomedical (LFCR) said Wednesday it has decided to continue with its standalone strategic plan after evaluating various alternatives, including reviewing more than 75 potential buyers. The co
No Data